CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+9.84%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$15.7B
AUM Growth
+$15.7B
(+6.5%)
Cap. Flow
-$63.5M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
22.96%
Holding
929
New
41
Increased
265
Reduced
360
Closed
129
Top Buys
| 1 |
Eli Lilly
LLY
|
$106M |
| 2 |
PayPal
PYPL
|
$58.2M |
| 3 |
Hologic
HOLX
|
$46.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.7M |
| 5 |
Intuitive Surgical
ISRG
|
$34.3M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$79.5M |
| 2 |
Merck
MRK
|
$77.4M |
| 3 |
Apple
AAPL
|
$62.7M |
| 4 |
Verizon
VZ
|
$37.8M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$36M |
Sector Composition
| 1 | Healthcare | 31.3% |
| 2 | Technology | 26.69% |
| 3 | Financials | 8.86% |
| 4 | Communication Services | 7.82% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
TG Therapeutics
TGTX
$4.72B
| $6.73M | 0.04% |
353,983
| – | – |
|
302
BridgeBio Pharma
BBIO
$9.56B
| $6.7M | 0.04% |
401,912
-53,373
| -12% | -$890K |
|
303
Nomad Foods
NOMD
$2.31B
| $6.65M | 0.04% |
261,925
+30,338
| +13% | +$770K |
|
304
Jack Henry & Associates
JKHY
$11.7B
| $6.64M | 0.04% |
39,740
-261
| -0.7% | -$43.6K |
|
305
Micron Technology
MU
$133B
| $6.63M | 0.04% |
71,157
-145,759
| -67% | -$13.6M |
|
306
Ford
F
$46.6B
| $6.61M | 0.04% |
318,089
-73,486
| -19% | -$1.53M |
|
307
Acadia Pharmaceuticals
ACAD
$4.33B
| $6.43M | 0.04% |
275,560
| – | – |
|
308
89bio
ETNB
$1.36B
| $6.38M | 0.04% |
488,197
| – | – |
|
309
Okta
OKTA
$15.8B
| $6.32M | 0.04% |
28,206
+18,313
| +185% | +$4.11M |
|
310
Denali Therapeutics
DNLI
$2.26B
| $6.31M | 0.04% |
141,507
+77,726
| +122% | +$3.47M |
|
|
TSC
311
DELISTED
TriState Capital Holdings, Inc.
TSC
| $6.27M | 0.04% |
+207,290
| New | +$6.27M |
|
312
Emcor
EME
$27.8B
| $6.25M | 0.04% |
49,052
+8,930
| +22% | +$1.14M |
|
|
ITCI
313
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.16M | 0.04% |
117,617
-367,849
| -76% | -$19.3M |
|
314
Beam Therapeutics
BEAM
$1.65B
| $6.15M | 0.04% |
77,147
| – | – |
|
315
Copart
CPRT
$46.9B
| $6.13M | 0.04% |
40,421
-1,095
| -3% | -$166K |
|
316
Yum! Brands
YUM
$40.4B
| $6.12M | 0.04% |
20,088
+4,160
| +26% | +$1.27M |
|
|
HARP
317
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $6.11M | 0.04% |
809,568
+320,054
| +65% | +$2.42M |
|
318
Credicorp
BAP
$20.6B
| $6.06M | 0.04% |
+49,600
| New | +$6.06M |
|
319
Norfolk Southern
NSC
$62.4B
| $6.02M | 0.04% |
20,231
-41,259
| -67% | -$12.3M |
|
320
Capital One
COF
$143B
| $6.01M | 0.04% |
41,396
-2,972
| -7% | -$431K |
|
|
AMED
321
DELISTED
Amedisys
AMED
| $5.95M | 0.04% |
+14,000
| New | +$5.95M |
|
|
DCPH
322
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $5.91M | 0.04% |
604,379
-103,738
| -15% | -$1.01M |
|
323
Rigel Pharmaceuticals
RIGL
$690M
| $5.89M | 0.04% |
2,221,696
| – | – |
|
324
Veeva Systems
VEEV
$44.1B
| $5.83M | 0.04% |
22,808
+2,341
| +11% | +$598K |
|
325
Paychex
PAYX
$49B
| $5.81M | 0.04% |
42,592
-7,572
| -15% | -$1.03M |
|